视网膜作为胎盘健康之窗:视网膜成像作为子痫前期与胎儿生长受限的新型生物标志物
子痫前期和胎儿生长受限是孕产妇与围产期致病的重要原因,视网膜作为可及的无创窗口可定量反映母体内皮功能障碍。光学相干断层扫描及其血管成像能快速无造影测量血管密度、中心凹无血管区几何及分层厚度。现有研究多为横断面、异质性大且样本量小,本文提出分阶段研究议程以推动视网膜成像的临床应用。
要点
- 视网膜成像可无创定量母体微循环,与子痫前期和胎儿生长受限的内皮功能障碍相关。
- 光学相干断层扫描血管成像可测量血管密度、中心凹无血管区及分层厚度,重复性高。
- 现有证据多为横断面、异质性大且样本量小,尚需前瞻性队列与实施性试验。
核心结论
- 视网膜成像有望作为子痫前期和胎儿生长受限的定量生物标志物,但现有证据多为横断面、异质性大且样本量小。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 光学相干断层扫描及其血管成像可快速、无造影测量血管密度、中心凹无血管区几何和分层厚度,重复性高。
- 新兴研究报告妊娠期高血压疾病中浅层毛细血管丛密度降低和高血压视网膜病变体征,早发型子痫前期效应更大。
- 现有证据多为横断面、异质性大且样本量小。
临床怎么用
- 作者提出潜在临床应用包括高风险女性靶向筛查、增强现有风险预测模型、纵向疾病监测和治疗反应评估。
- 作者提出分阶段研究议程:统一采集与质量标准;前瞻性孕期特异性队列连接视网膜指标与母儿结局;机制性子研究关联视网膜特征与全身血流动力学;实施性试验评估可行性、公平性及对母儿结局的影响。
局限性
- 证据多为横断面、异质性大且样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia (PE) and fetal growth restriction (FGR) are major causes of maternal and perinatal morbidity. The retina, an accessible and non-invasive window to the systemic microcirculation, offers quantitative biomarkers of maternal endothelial dysfunction that are central to development of PE and FGR. Advances in optical coherence tomography and Optical Coherence Tomography Angiography (OCTA) enable rapid, contrast-free measurement of vessel density, foveal avascular zone geometry and layer-specific thickness with high reproducibility. Emerging studies report reduced superficial capillary plexus density and hypertensive retinopathy signs in hypertensive disorders of pregnancy, with larger effects in early-onset PE. However, evidence remains mostly cross-sectional, heterogeneous and limited by small sample size. We describe potential clinical applications including targeted screening of high-risk women, enhancement of existing risk prediction models, longitudinal disease monitoring and assessment of treatment response. A staged research agenda is proposed, as following: (1) harmonized acquisition and quality standards; (2) prospective, trimester-specific cohorts linking retinal metrics to maternal and perinatal outcomes; (3) conducting mechanistic substudies to relate retinal signatures to systemic hemodynamics; 4) performing implementation trials to evaluate feasibility, equity and the impact on maternal and perinatal outcomes.
引用
- Saccone G, Matarazzo F, Motta M, et al. The eye as a window to placental health: retinal imaging as a novel biomarker for preeclampsia and fetal growth restriction. Am J Obstet Gynecol MFM. 2025. PMID: 41276219. doi:10.1016/j.ajogmf.2025.101855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。